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Cdk1 orders mitotic events through coordination
of a chromosome-associated phosphatase switch
Junbin Qian1, Monique Beullens1, Jin Huang1,2, Sofie De Munter1, Bart Lesage1 & Mathieu Bollen1
RepoMan is a scaffold for signalling by mitotic phosphatases at the chromosomes. During
(pro)metaphase, RepoMan-associated protein phosphatases PP1 and PP2A-B56 regulate the
chromosome targeting of Aurora-B kinase and RepoMan, respectively. Here we show that this
task division is critically dependent on the phosphorylation of RepoMan by protein kinase
Cyclin-dependent kinase 1 (Cdk1), which reduces the binding of PP1 but facilitates the
recruitment of PP2A-B56. The inactivation of Cdk1 in early anaphase reverses this
phosphatase switch, resulting in the accumulation of PP1-RepoMan to a level that is sufficient
to catalyse its own chromosome targeting in a PP2A-independent and irreversible manner.
Bulk-targeted PP1-RepoMan also inactivates Aurora B and initiates nuclear-envelope
reassembly through dephosphorylation-mediated recruitment of Importin b. Bypassing the
Cdk1 regulation of PP1-RepoMan causes the premature dephosphorylation of its mitotic-exit
substrates in prometaphase. Hence, the regulation of RepoMan-associated phosphatases by
Cdk1 is essential for the timely dephosphorylation of their mitotic substrates.
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C
yclin-dependent kinase 1 (Cdk1) is the master regulator of
mitosis1. It is activated at the G2-M transition, reaches its
maximal activity in prometaphase and is inactivated at the
metaphase–anaphase transition. Cdk1 triggers the mitotic entry
and controls the initial phases of mitosis by phosphorylation
of key regulators of processes as diverse as chromosome
condensation, spindle assembly and nuclear-envelope breakdown.
In addition, Cdk1 restrains proteins that are only needed at later
stages of mitosis. Among the most important Cdk1 substrates are
other mitotic kinases, including Aurora B and Haspin2–4.
However, Cdk1 also regulates protein phosphatases PP1 and
PP2A, the main mitotic phosphatases in vertebrates5,6. PP1 forms
heterodimers or heterotrimers with a host of regulatory subunits
that define when and where the phosphatase acts. Cdk1 inhibits
PP1 both by preventing the binding of some regulatory subunits
and by decreasing the specific activity of the catalytic subunit7,8.
PP2A holoenzymes usually consist of a catalytic subunit, a
scaffolding A subunit and a variable, substrate-specifying B
subunit. The mitotically important B subunits are isoforms of B55
and B56. Cdk1 inhibits PP2A-B55 and a kinetochore pool of
PP2A-B56 by activation of inhibitory proteins9,10. In contrast,
Cdk1 promotes the recruitment of PP2A-B56 to the kinetochore
protein BubR1 (ref. 11).
The phosphatase scaffold RepoMan, also known as CDCA2,
binds directly to both PP1 (ref. 12) and PP2A-B56 (refs 13,14).
In prometaphase, RepoMan-associated PP1 dephosphorylates
Histone H3 at Thr3 (H3T3) on the chromosome arms15. Since
phosphorylated (ph) H3T3 serves as a docking site for Survivin, a
subunit of the Aurora-B or chromosomal passenger complex
(CPC), the selective dephosphorylation of H3T3ph on the
chromosome arms contributes to the centromeric enrichment
of the CPC16–18. Centromeric H3T3ph is protected from
dephosphorylation by PP1-RepoMan until anaphase because
RepoMan is prevented from binding to histones through
Aurora-B-mediated phosphorylation at S893, in particular at
the centromeres where Aurora B is most active13. The
centromeric targeting of the CPC is further enhanced by a
reciprocal positive feedback loop between Aurora B and Haspin,
the H3T3 kinase19. Importantly, the chromosome targeting of
RepoMan during (pro)metaphase is highly dynamic, because
RepoMan-associated PP2A-B56 counteracts Aurora B by
dephosphorylating RepoMan at S893 (ref. 13). Thus, the
interplay between Haspin, Aurora B and RepoMan-associated
phosphatases couples reciprocal positive and double-negative
feedback loops to establish a robust and dynamic mechanism for
the centromeric targeting of the CPC in (pro)metaphase
(Supplementary Fig. 1)6. At the beginning of anaphase, the
CPC is translocated to the spindle midzone enabling the
complete dephosphorylation of RepoMan at S893 and its bulk
recruitment to chromosomes. Considerable evidence indicates
that the RepoMan-associated phosphatase activity then catalyses
the dephosphorylation of hitherto unidentified substrates
that contribute to chromosome segregation, chromosome
decondensation and nuclear-envelope reassembly8,20,21.
Cdk1 promotes the centromeric targeting of the CPC at
different levels (Supplementary Fig. 1). It phosphorylates and
activates Haspin3,4, but also enhances CPC binding to
centromeric Shugoshin through phosphorylation of the CPC
subunit Borealin2. In addition, Cdk1 opposes the chromosomal
targeting of RepoMan8,20, but the underlying mechanism and the
importance of this regulation are not clear. Here, we show that
Cdk1 has opposite effects on RepoMan-associated PP1 and
PP2A-B56. Cdk1 reduces the binding and activity of PP1 to
levels that are sufficient to keep the chromosome arms
dephosphorylated at H3T3, but below the threshold needed
to dephosphorylate centromeric H3T3 and other anaphase
substrates. On the other hand, Cdk1 promotes the recruitment
of PP2A-B56, which dephosphorylates RepoMan at S893 and
thereby balances Aurora B to set the level of chromosome-
targeting of RepoMan in (pro)metaphase. The inactivation
of Cdk1 at the beginning of anaphase induces a phosphatase
switch on RepoMan that culminates in the bulk recruitment
of PP1-RepoMan to chromosomes and the timely
dephosphorylation of key regulators of the mitotic exit.
Results
Cdk1 limits the chromosome targeting of RepoMan. The
inhibition of Cdk1 induces the recruitment of RepoMan to
chromosomes in chicken DT40 cells8,20. We noted that the
Cdk1 inhibitor Roscovitine (Fig. 1a) also induced a massive
chromosome targeting of ectopically expressed EGFP-tagged
RepoMan in prometaphase-arrested U2OS cells. This effect was
not seen with the S893D mutant. Since S893 phosphorylation or
the S893D mutation preclude the binding of RepoMan to
histones13, these findings suggested that Cdk1 inhibition caused
the chromosome targeting of RepoMan through a reduced
activity of Aurora B and/or the activation of a counteracting
phosphatase. The (auto)activation of Aurora B is critically
dependent on its centromeric enrichment22 and Cdk1 enhances
centromeric CPC recruitment through both the Borealin-
Shugoshin and Survivin-H3T3ph pathways2,16–18. Accordingly,
Roscovitine caused the loss of Aurora B from the centromeres
(Fig. 1b). However, the artificial targeting of Aurora B to
centromeres by overexpression of the CPC component INCENP
fused to the centromeric protein CENP-B19 did not significantly
reduce the Roscovitine-induced chromosome hypertargeting of
RepoMan (Fig. 1b,c). In contrast, this Roscovitine effect was
largely abolished by Calyculin A (Fig. 1d,e), an inhibitor of
PP1 and PP2A(-like) phosphatases, suggesting a dependency
on phosphatase activity. Since both PP1 and PP2A-B56 are
associated with RepoMan during prometaphase, we subsequently
examined whether Roscovitine had distinct effects on the
chromosome targeting of previously characterized phosphatase-
binding mutants of RepoMan13. Dose–response curves revealed a
reduced sensitivity to Roscovitine after mutation of either the
RVxF-type PP1-binding site (RATA mutant) or the LSPI-type
B56-binding site (LAPA mutant) (Fig. 1f). The combined
mutations had an additive effect. This suggested that the
Roscovitine-induced chromosome hypertargeting of RepoMan
was dependent on associated PP1 and PP2A.
Cdk1 has opposite effects on the binding of PP1 and PP2A-B56.
To understand how Cdk1 regulates the RepoMan-associated
phosphatases, we first examined how the binding of PP1 and
PP2A-B56 to endogenous RepoMan evolved after the release of
U2OS cells from a Nocodazole arrest in prometaphase (Fig. 2a).
During prometaphase, little PP1 was associated with immuno-
precipitated RepoMan, but the binding of PP1 increased con-
siderably during anaphase when the Cdk1-regulatory subunit
Cyclin B got degraded. Eventually, the association of PP1 with
RepoMan at the end of mitotic exit was similar to that in
non-synchronized cells. In contrast, the binding of PP2A-B56 to
RepoMan was maximal in prometaphase, rapidly decreased in
anaphase and was nearly undetectable 2 h after the Nocodazole
release and in non-synchronized cells. Similar results were
obtained for ectopically expressed EGFP-tagged RepoMan
(Fig. 2b). Moreover, a shift from PP2A to PP1 binding could also
be provoked by the inhibition of Cdk1 with Roscovitine (Fig. 2c),
indicating that this phosphatase switch is controlled by Cdk1.
This notion was consistent with the finding that both Cdk1
and Cyclin B co-precipitated with EGFP-RepoMan (Fig. 2d).
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Using deletion mutagenesis the Cyclin B/Cdk1-binding site was
mapped to residues 403–550, between the binding sites of PP1
and PP2A-B56 (Fig. 2e).
Cdk1 opposes PP1-RepoMan. To find out how Cdk1 affects
PP1-RepoMan, we first performed an in silico analysis of the
PP1-binding domain of RepoMan. Recent structural data revealed
that regulatory subunits of PP1 often have multiple PP1-binding
motifs23. For example, PNUTS and Spinophilin contain a
tripartite PP1-binding domain that comprises appropriately
spaced RVxF, FF and Arg binding motifs (Fig. 3a). The
consensus sequence for this tripartite binding motif is also
present in the PP1-binding domain of RepoMan and is
phylogenetically conserved (Fig. 3a,b). Mutation of either of
these binding motifs abolished or decreased the binding of PP1 to
ectopically expressed EGFP-RepoMan (Fig. 3c). The separate
mutation of the two basic residues of the putative Arg motif
showed that PP1-binding was only affected by mutation of K416.
Thus, RepoMan has a functional tripartite PP1-binding domain.
The three PP1-binding motifs of RepoMan are each
C-terminally flanked by a conserved SP or TP (Fig. 3b),
representing putative phosphorylation motifs for Cdks.
Consistent with previous data in DT40 cells8,20, RepoMan was
hyperphosphorylated in mitotically arrested U2OS cells, as
suggested by its reduced mobility during SDS–polyacrylamide
gel electrophoresis (Fig. 3d). Mutation of the putative Cdk sites
S400, T412 and T419 in the PP1-binding domain of RepoMan
into an alanine, further referred to as RepoMan-3A, reduced this
mobility shift and increased the binding of PP1. This suggested
that Cdk1 opposes the RepoMan-PP1 interaction through
phosphorylation of RepoMan at these sites. Phosphorylation of
S400 and T412 have been detected in previous proteomics
studies14,24,25. In addition, we raised a phospho-epitope-specific
antibody against T412 of RepoMan. This residue was previously
shown to be the major Cdk1 phosphorylation site that regulates
the PP1-RepoMan interaction in DT40 cells8. The antibody
visualized WT EGFP-RepoMan but not the T412A mutant in
traps from mitotic cell lysates, confirming its specificity (Fig. 3e).
In addition, the immunoblot signal was detected in lysates from
mitotic cells but not from non-synchronized cells, supporting the
notion that T412 was only phosphorylated during mitosis. In
addition, T412 was phosphorylated in vitro by both Cdk2/Cyclin
A (Supplementary Fig. 2) and Cdk1/Cyclin B. These Cdks have
the same in vitro substrate specificity and are thus equivalent for
biochemical studies26. Next, we generated phosphomimicking
mutants for T412 separately (RepoMan-T412D) or for all three
Cdk sites together (RepoMan-3D). RepoMan-T412D showed less
PP1 binding but the 3D mutant caused a more prominent drop,
indicating that the phosphorylation of S400 and/or T419 also
contribute to the attenuation of PP1 binding (Fig. 3f,g). To
further validate these findings, we phosphorylated RepoMan-wild
type (WT) or RepoMan-3A from non-synchronized cells
with Cdk2/Cyclin A (Fig. 3h). Cdk phosphorylation caused
the dissociation of PP1 from RepoMan-WT but not from
RepoMan-3A, confirming that phosphorylation of the Cdk sites
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Figure 1 | Cdk1 opposes the chromosome targeting of RepoMan. (a) Nocodazole-arrested U2OS cells transiently expressing EGFP-tagged RepoMan-WT
or RepoMan-S893D were treated with dimethyl sulfoxide (DMSO) (control) or Roscovitine (100mM) for 30min before fixation and visualization of EGFP
and DNA. The numbers in the figures refer to the percentage of cells where the shown phenotype occurred. Scale bars, 5mm. (b) Confocal images of
Nocodazole-arrested U2OS cells, in the absence or presence of Roscovitine (Rosc) and transiently expressed EGFP-tagged CENP-B (CB) fused to INCENP.
The fixed cells were stained for endogenous RepoMan, Aurora B and DNA. Scale bars, 5 mm. (c) Quantification of RepoMan localization in b. The graphs
show mean percentages±s.e.m. from three independent experiments (Z73 cells for each condition per experiment). ***Po0.001 in paired t-test,
compared with control (Ctrl). (d) Nocodazole-arrested U2OS cells were treated with DMSO (control) or 100mM Roscovitine for 30min, as such or in
combination with 20 nM Calyculin A (CA). The fixed cells were stained for endogenous RepoMan and DNA. Scale bars, 5 mm. (e) Quantification of EGFP-
RepoMan localization in d. Graphs show mean percentages±s.e.m. from three independent experiments (Z74 cells for each condition per experiment).
**Po0.01 in paired t-test, compared with control (Ctrl). (f) Nocodazole-arrested U2OS cells expressing the indicated EGFP-tagged RepoMan variants were
incubated for 30min with different concentrations of Roscovitine before fixation. DNA was stained with DAPI. The figure shows the percentage of cells
where the EGFP-fusion was chromosome-associated. The results are expressed as means±s.e.m. from three independent experiments (Z103 cells per
data point).
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in the PP1-binding region caused the disruption of the
PP1-RepoMan complex (Fig. 3h).
The C-terminus of all PP1 isoforms contains a conserved
Cdk phosphorylation site7. Phosphorylation of this site (PP1ph)
reduces the catalytic efficiency of PP1. Using a phospho-
epitope-specific antibody, RepoMan-associated PP1 was found
to be phosphorylated in prometaphase-arrested U2OS cells
(Fig. 3i). As expected, this phosphorylation was barely
detected in RepoMan-associated PP1 from non-synchronized
cells. Moreover, PP1 that was trapped with RepoMan-3A from
lysates of non-synchronized cells could be readily phosphorylated
in vitro (Fig. 3j). However, this does not imply that the Cdk1-
mediated phosphorylation of PP1 is dependent on RepoMan.
In conclusion, Cdk1 not only reduces the recruitment of PP1 but
also phosphorylates RepoMan-associated PP1 to decrease its
specific activity.
Cdk1 promotes the binding of PP2A-B56 to RepoMan. Next,
we explored how Cdk1 regulates the interaction of RepoMan with
PP2A-B56. Treatment of EGFP-RepoMan traps from mitotic
U2OS cell lysates with lambda phosphatase decreased the binding
of PP2A-B56 (Fig. 4a), indicating that the interaction between
RepoMan and PP2A-B56 was phosphorylation-dependent.
To identify which component was modified, we first trapped
EGFP-tagged RepoMan from non-synchronized and mitotic
cell lysates, and washed the traps with 1.5M NaCl to remove
associated PP2A. The purified fusions were then added back to
mitotic lysates and examined for rebinding of PP2A. In these
conditions, EGFP-RepoMan from mitotic lysates bound much
more PP2A than that from lysates of non-synchronized cells
(Fig. 4b). Since mitotic RepoMan was equally efficient in binding
PP2A from interphase and mitotic lysates (Supplementary
Fig. 3a), these data demonstrate that the RepoMan-PP2A
interaction is enhanced by a mitosis-specific modification of
RepoMan.
The kinetochore protein BubR1 contains a LSPI-type binding
motif for the B56 subunit of PP2A that is phosphorylated by
Cdk1 (refs 11,13). S591 in the equivalent B56-binding motif of
RepoMan also represents a consensus Cdk phosphorylation
site13. To examine whether this site is phosphorylated during
mitosis, we made an antibody against a synthetic peptide that
includes S591. This antibody turned out to be specific for the
non-phosphorylated (nph) peptide (Supplementary Fig. 3b). The
S591nph-specific antibody visualized ectopically expressed
EGFP-RepoMan on immunoblots from non-synchronized cell
lysates but not from mitotic lysates (Fig. 4c). However, an
interphase signal was absent after mutation of S591 (Fig. 4c) and
mitotic RepoMan could be detected after Cdk1 inhibition
(Fig. 4d). Immunostaining of fixed U2OS cells with the
S591nph-specific antibody barely visualized RepoMan from
prometaphase to early anaphase (Fig. 4e), consistent with its
phosphorylation by Cdk1 in vivo. However, RepoMan was
present throughout mitosis as it could be detected
with a (phosphorylation-independent) pan-RepoMan antibody.
Collectively, these data show that S591 is phosphorylated by Cdk1
and dephosphorylated again in early anaphase.
To delineate the effect of S591 phosphorylation on the
recruitment of PP2A-B56, we purified EGFP-tagged RepoMan-
WT and RepoMan-S591A from non-synchronized cells,
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Figure 2 | Cdk1 regulates the association of PP1 and PP2A-B56 with RepoMan. (a) Nocodazole-arrested prometaphase U2OS cells were collected by
shake-off and then released into fresh medium for different time points to synchronize the cells for mitotic exit. Immunoprecipitates (IP) of endogenous
RepoMan were prepared from lysates of these synchronized cells as well as from non-synchronized cells. The IPs were analysed by immunoblotting with
the indicated antibodies. Asterisk denotes IgG-heavy chain. (b) U2OS cells were transfected with EGFP-RepoMan-WTand arrested/released as in a. EGFP
traps of cell lysates were analysed by immunoblotting. (c) Nocodazole-arrested U2OS cells were collected by shake-off and then treated with or without
100mM Roscovitine for 30min. EGFP traps from cell lysates were analysed by immunoblotting. (d) EGFP traps of lysates from Nocodazole-arrested
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phosphorylated the fusions in vitro with Cdk2 and examined the
effect on PP2A binding from mitotic cell lysates. With
progressing phosphorylation of EGFP-RepoMan-WT, as shown
by mobility shifts and the disappearance of the S591nph signal,
more PP2A was retained from mitotic lysates (Fig. 4f). The
binding of PP2A was severely reduced with the S591A mutant,
illustrating its dependency on S591 phosphorylation. However,
this mutant still showed some Cdk-dependent phosphatase
binding, suggesting that additional Cdk1 site(s) may contribute
to the interaction with PP2A. Consistent with a Cdk-enhanced
binding of PP2A, a synthetic LSPI-containing peptide coupled to
Sepharose beads pulled down more PP2A from mitotic lysates
when it was phosphorylated on S591 (Supplementary Fig. 3b).
In contrast, Cdk phosphorylation of EGFP-PP2A-B56g purified
from non-synchronized cell lysates did not affect its binding to
RepoMan from mitotic lysates (Supplementary Fig. 3c), indicat-
ing that Cdks do not promote the RepoMan/PP2A-B56
interaction through phosphorylation of the PP2A-B56 complex.
In further agreement with these in vitro data, we found that the
EGFP-RepoMan-S591A mutant showed a reduced binding of
PP2A when trapped from mitotic cell lysates (Fig. 4g). However,
the S591D mutant also bound less PP2A, indicating that this
mutant is not phosphomimicking.
Cdk1 inactivation makes RepoMan targeting irreversible. The
bulk recruitment of RepoMan to chromosomes in early anaphase
requires its dephosphorylation at S893 but coincides with the
dissociation of PP2A-B56, indicating that another phosphatase
dephosphorylates S893 at this stage. To identify the RepoMan-
S893 phosphatase in anaphase, we generated stable HeLa cell lines
(Flp-in/T-Rex system) that inducibly express siRNA-resistant
EGFP-tagged fusions of RepoMan variants, that is, the WT
protein, a PP1-binding mutant (RATA), a PP2A-binding mutant
(LAPA), a PP1þ PP2A-binding mutant (RATAþ LAPA) and a
histone-binding mutant (S893D). The RepoMan fusions were
expressed to similar levels as endogenous RepoMan (Fig. 5a).
Using time-lapse live imaging, we determined the kinetics of
chromosome binding of the EGFP-RepoMan fusions during
anaphase after the knockdown of endogenous RepoMan (Fig. 5a).
The experiments were performed in cells that were released
from a Monastrol-induced prometaphase arrest (Fig. 5b,c) and
in unperturbed cells (Supplementary Fig. 4a), with a similar
outcome.
Quantification of the data from Monastrol-released cells
showed that the recruitment of RepoMan-WT started quickly
after the onset of anaphase and was half-maximal after 2–3min
(Fig. 5c). The LAPA mutant was recruited almost as fast as the
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WT protein, while the RATA mutant showed a slower targeting,
with half-maximal binding after 7–8min. These data indicated
that the chromosome targeting of RepoMan in early anaphase
mainly depends on PP1, rather than PP2A-B56, coinciding with
the increased recruitment of PP1 by RepoMan. This view was
substantiated by in vitro data showing that a C-terminal
RepoMan fragment that was phosphorylated at S893 could
be dephosphorylated by purified PP1 and by EGFP-tagged
RepoMan-WT and RepoMan-LAPA that were trapped from
non-synchronized cells (Supplementary Fig. 4b). However, this
dephosphorylation was not seen with the RepoMan-RATA
mutant. Thus, the switch in the dephosphorylation of Repo-
Man-S893 from PP2A-B56 in (pro)metaphase to PP1 in anaphase
makes the chromosome targeting of RepoMan Cdk1-independent
and irreversible. Interestingly, the RATAþ LAPA mutant showed
a further delay in chromosome binding, as compared with the
RATA mutant, suggesting that PP2A-B56 still promotes the
chromosome targeting of RepoMan when the PP1-binding site
is mutated. This is possibly due to a slower dissociation of
PP2A-B56 from RepoMan RATA, as suggested by the delayed
appearance of the S591nph signal in the RATA mutant
(Supplementary Fig. 4c). However, further investigations are
required to examine how PP1 contributes to the removal of
PP2A-B56 from RepoMan in anaphase.
The histone-binding mutant (S893D) of RepoMan only started
to co-localize massively with the chromosomes at B8min after
the beginning of anaphase (Fig. 5c). This corresponds to the time
of initiation of nuclear import27 and therefore probably reflects
RepoMan import rather than chromosome binding. Indeed, the
S893D mutant only started to co-localize with the chromosomes
when Lamin B1, a marker for nuclear import establishment, was
already concentrated on the nuclear rim (Supplementary Fig. 4d).
Moreover, C-terminal deletion mutants of RepoMan, which lack
the histone-binding domain but still contain the Importin-b
binding domain and putative consensus nuclear localization
signals, were also targeted to the nucleus in telophase
(Supplementary Fig. 4e).
In prometaphase cells the detection of chromosome association
of RepoMan is lost by fixation but can be readily visualized by
live imaging. RepoMan-RATA showed a normal, that is, partial
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chromosome localization in prometaphase, but RepoMan-LAPA
was excluded from the chromosomes (Fig. 5d,e), in accordance
with the dephosphorylation of RepoMan at S893 by associated
PP2A-B56 (ref. 13). Since PP1 emerged as the major RepoMan-
S893 phosphatase in anaphase, we speculated that an anaphase-
like, chromosome hypertargeting of RepoMan could already be
induced in prometaphase by the expression of RepoMan-3A,
which bypasses the downregulation of PP1 binding by Cdk1.
Indeed, RepoMan-3A was already massively chromosome-
associated in prometaphase, as detected by live imaging
(Fig. 5d,e). This hypertargeting phenotype was not seen with
the double mutants RepoMan-3AþRATA and RepoMan-3Aþ
S893D, indicating that it depended on both PP1 and the
dephosphorylation of S893. Also, the hypertargeting was reduced
with the RepoMan-3Aþ LAPA mutant, suggesting that it was
mediated by both PP1 and PP2A-B56.
Cdk1 activates Aurora B through inhibition of PP1-RepoMan.
As the downregulation of PP1-RepoMan by Cdk1 prevented
the precocious bulk dephosphorylation of RepoMan at S893,
we asked whether this also applies to other mitotic-exit substrates
of PP1-RepoMan. In prometaphase-arrested Flp-in/T-Rex cells,
the induction of RepoMan-WT rescued the H3T3 hyper-
phosphorylation phenotype caused by the knockdown of
endogenous RepoMan (Fig. 6a,b and Supplementary Fig. 5a).
However, the induction of RepoMan-3A also caused a premature
dephosphorylation of centromeric H3T3 in prometaphase and,
consequently, the loss of Aurora B and its substrate MCAK from
the centromeres (Fig. 6a,b and Supplementary Fig. 5b,c). In
addition, RepoMan-3A strongly reduced the Aurora-B activity,
as indicated by its decreased autophosphorylation at T232
(Fig. 6c,d), and the decreased phosphorylation of histone H3
at S10 (H3S10ph), an established Aurora-B substrate on the
a
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chromosome arms (Fig. 6e,f). The loss of Aurora-B activity and
H3S10ph cannot be solely explained by the reduced centromeric
targeting of Aurora B via H3T3ph, since preventing H3T3
phosphorylation by the knockdown of Haspin affects neither the
Aurora-B activity nor the level of H3S10ph (ref. 16). In further
agreement with a loss of Aurora-B function, the expression of
RepoMan-3A in the absence of endogenous RepoMan increased
chromosome misalignment in cells that were released from
a prometaphase arrest in the presence of MG132 (Fig. 6g,h).
Aurora B is also implicated in the activation of the spindle
checkpoint28. The expression of RepoMan-3A weakened the
spindle checkpoint, as indicated by the reduced association of the
checkpoint protein Mad2 with the kinetochores (Fig. 6i,j) and
the override of the mitotic arrest in the presence of 3.3 mM
nocodazole (Supplementary Fig. 5d). Since ectopically expressed
RepoMan-3A bypasses Cdk1 regulation of associated PP1, these
data demonstrate that restraining PP1-RepoMan is essential to
maintain Aurora-B activity in (pro)metaphase.
Aurora B was also inactivated following the chromosome
hypertargeting of endogenous RepoMan by Roscovitine. This
Aurora-B inactivation was barely affected by the artificial
tethering of Aurora B to the centromeres with CENPB-INCENP
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(Supplementary Fig. 5e,f), but was prevented by the addition of
the phosphatase inhibitor Calyculin A (Supplementary Fig. 5g,h)
suggesting that the inactivation of Aurora B was phosphatase-
dependent. Since Cdk1 promotes Aurora B activation through
multiple pathways (Supplementary Fig. 1), we have tried to
delineate the contribution of PP1-RepoMan. The knockdown of
RepoMan reduced the Roscovitine-induced Aurora B inactivation
from B10 to 60% (Supplementary Fig. 5i,j). This effect was
completely rescued by co-expression of siRNA-resistant WT
EGFP-RepoMan, but only partially by the RepoMan-3D mutant.
These data show that RepoMan is important for the control of
Aurora B by Cdk1, but it cannot be excluded that this function of
RepoMan is partially PP1-independent. Finally, we sought to
examine whether PP1-RepoMan can directly dephosphorylate
Aurora B. Indeed, the autophosphorylated Aurora B/INCENP
complex was dephosphorylated by purified PP1 (Supplementary
Fig. 5k) and RepoMan-WT isolated from lysates of non-
synchronized cells (Fig. 6k). However, RepoMan-RATA failed
to dephosphorylate this Aurora B complex, confirming that it
required PP1.
Cdk1 and PP1-RepoMan regulate the recruitment of Importin b.
The (peri)chromosomal recruitment of Importin b in anaphase,
which functions as a seeding factor for the initiation of nuclear-
envelope reassembly29, was reduced by the knockdown of
RepoMan in DT40 cells8 and U2OS cells (Fig. 7a). This effect
was lost in late telophase, suggesting that the recruitment of
Importin b is biphasic and that RepoMan only affects the early
recruitment of Importin b. Conversely, the Roscovitine-induced
chromosome hypertargeting of RepoMan in prometaphase cells
also caused a hypertargeting of Importin b to the chromosomes,
which was alleviated by the knockdown of RepoMan (Fig. 7b,c).
However, the inhibition of Aurora B with Hesperadin, which also
endorses chromosome targeting of RepoMan in prometaphase,
did not result in a premature recruitment of Importin b to
the chromosomes (Fig. 7d,e). Similar data were obtained for the
nucleoporin Nup153 (Supplementary Fig. 6a), which is an
interactor of both Importin b and the N-terminus of
RepoMan8. These data indicated that the chromosome
recruitment of importin b in early anaphase depends on
RepoMan and that the Importin-b/RepoMan interaction is
opposed by Cdk1, consistent with previous data in DT40 cells8.
Indeed, more Importin b was associated with EGFP-trapped
RepoMan after the addition of Roscovitine to prometaphase-
arrested cells (Fig. 7f). Also, purified interphase EGFP-tagged
RepoMan retained much less Importin b from mitotic lysates
after Cdk phosphorylation (Fig. 7g). In contrast, Cdk
phosphorylation of EGFP-tagged Importin b did not affect its
ability to bind RepoMan (Supplementary Fig. 6b).
The Importin-b binding domain of RepoMan (residues 1–135)
contains eight potential Cdk phosphorylation sites (Supplementary
Fig. 6c) and four of these are known to be hyperphosphorylated in
mitosis24,25,30. When the eight putative Cdk1 sites were mutated
into a phosphomimicking 8D mutant, RepoMan-(1–135) could no
longer be phosphorylated by Cdk2 (Fig. 7h). Moreover, the
corresponding full-length RepoMan-8D did not bind to Importin b
in cell lysates (Fig. 7i). Alanine mutation of the N-terminal Cdk
sites also reduced the binding of Importin b (data not shown), but
further investigations revealed that this unexpected result can be
explained by the requirement of one of these sites (Thr68) for
Importin-b binding, as mutation of Thr68 to any of four tested
residues compromised Importin-b binding (Supplementary
Fig. 6d). Interestingly, changing the Cdk consensus by mutating
Pro69 to Thr preserved the Importin-b binding (Supplementary
Fig. 6d).
Since inactivation of Cdk1 promotes the RepoMan/Importin b
interaction, which is correlated with an increased PP1-RepoMan
interaction, we hypothesized that the Importin-b binding site
of RepoMan is a substrate for associated PP1. Accordingly,
replacement of endogenous RepoMan by RepoMan-3A, which
is hypertargeted to chromosomes and is constitutively
associated with PP1, induced a partial or complete premature
(peri)chromosome recruitment of Importin b in Nocodazole-
arrested cells (Fig. 7j). However, the forced targeting of
RepoMan-WT to prometaphase chromosomes by its fusion with
histone H2B did not cause the co-recruitment of Importin b in
prometaphase (Fig. 7k). This showed that chromosome targeting
of RepoMan per se, even when combined with prometaphase
levels of associated PP1, was not sufficient for the co-recruitment
of Importin b. However, the prometaphase recruitment of
Importin b induced by the expression of H2B fused to
RepoMan-3A was lost by mutation of the RVxF-type PP1
binding motif, revealing its PP1 dependency. Interestingly, we
found that RepoMan-3A also induced a premature association of
Nup153, another early nuclear-envelope seeding factor, to the
(peri)chromosomal area during anaphase (Supplementary
Fig. 6e). In contrast, RepoMan-3A did not affect the distribution
of Lamin B1, which marks the end of nuclear-envelope
reassembly (Supplementary Fig. 6f). These data indicate that
the RepoMan pathway is only one of multiple processes that are
involved in nuclear-envelope reassembly. Finally, purified PP1
(Supplementary Fig. 6g) and EGFP-tagged PP1-RepoMan
(Fig. 7l) trapped from non-synchronized cells were able to
dephosphorylate Cdk-phosphorylated RepoMan-(1–135) in vitro.
The dephosphorylation was specific for PP1 as it was lost by
mutation of the PP1-binding site but not by mutation of the
PP2A-binding site. Collectively, these data strongly suggest that
Cdk1 and PP1 antagonistically regulate the binding of Importin b
to RepoMan. However, it should be noted that the localization of
RepoMan and Importin b were not completely identical after the
inhibition of Cdk1 or the expression of RepoMan-3A
(Fig. 7b,d,j,k), in that RepoMan was more prominently associated
with the chromosomes, whereas Importin b was preferentially
targeted to the chromosomal periphery. It therefore seems likely
that the RepoMan-Importin b interaction is somehow opposed
on the chromosome and/or that PP1-RepoMan dephosphorylates
additional substrates to enhance the association of Importin b
with the chromosomal periphery.
Discussion
Our data revealed that the regulation of RepoMan-associated
phosphatases by Cdk1 is critical for the ordered dephosphoryla-
tion of their substrates in (pro)metaphase and anaphase (Fig. 8).
On the one hand, Cdk1 promotes the recruitment of PP2A-B56
to reverse the Aurora-B-mediated phosphorylation of RepoMan
at S893 in the histone-binding site (Fig. 4). Hence, it is the
balance between Aurora B and PP2A-B56 that determines how
much RepoMan is chromosome-associated during (pro)meta-
phase. This is probably a highly dynamic process because Cdk1
also stimulates the recruitment of Aurora B to the centromeres
(Supplementary Fig. 1), which limits the chromosome targeting of
RepoMan. On the other hand, Cdk1 reduces the binding of PP1
to RepoMan and phosphorylates associated PP1 (Fig. 3), which is
known to decrease its catalytic efficiency7. The remaining pool of
chromosome-associated PP1-RepoMan is essential and sufficient
to dephosphorylate H3T3 on the chromosome arms, in
agreement with the finding that H3T3ph is an extremely
good substrate for PP1-RepoMan, even when compared with
other histone H3 phosphorylation sites15. The preferential
dephosphorylation of histone H3 at Thr3 is also in accordance
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with compelling data showing that the substrate quality
governs the order of protein dephosphorylation by mitotic
phosphatases31. Centromeric H3T3ph is protected from
dephosphorylation during (pro)metaphase because the
recruitment of PP1-RepoMan is locally opposed by Aurora B,
which is most active at the centromeres13. The significance of
the Cdk1-mediated downregulation of chromosome-associated
PP1-RepoMan is probably that it prevents the dephosphorylation
of substrates, including Aurora B and the histone/importin-b-
binding sites of RepoMan, that only need to be dephosphorylated
in anaphase. Consistent with this proposal, we found that
bypassing the Cdk1 regulation of PP1-RepoMan, either by the
expression of RepoMan-3A or inhibition of Cdk1, caused
the premature dephosphorylation of these substrates in
prometaphase (Figs 5–7).
The inactivation of Cdk1 in early anaphase induces a
phosphatase switch in that PP2A-B56 is dissociated from
RepoMan, whereas PP1 is recruited more prominently (Figs 2
and 8). Moreover, RepoMan-associated PP1 is expected to
become more active through autocatalytic dephosphorylation of
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(1–135)-WT or RepoMan-(1–135)-8D were radioactively phosphorylated with Cdk2 and analysed by autoradiography and Coomassie staining. (i) EGFP
traps from HEK293T cells expressing EGFP-tagged RepoMan-WT or RepoMan-8D were analysed by immunoblotting for the binding of Importin b.
(j) Nocodazole-arrested HeLa Flp-in T-Rex cells were transfected with control or RepoMan siRNAs, and induced to express EGFP-tagged RepoMan-WT
or RepoMan-3A before staining. The numbers in the figures refer to the percentage of cells where the shown phenotype occurred. Scale bars, 5mm.
(k) Nocodazole-arrested Hela cells expressing H2B fusions of RepoMan-WT, RepoMan-3A and RepoMan-3Aþ RATA. Scale bars, 5 mm. (l) EGFP traps of
the indicated RepoMan variants from non-synchronized HEK293T cells were used as a phosphatase source to dephosphorylate Cdk2-phosphorylated
His-tagged RepoMan-(1–135).
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its Cdk-phosphorylated C-terminus7. This phosphatase switch in
early anaphase ends the collaboration between PP2A-B56 and
PP1 that contributed to the centromeric targeting of the CPC
through dephosphorylation of RepoMan-S893 and H3T3,
respectively. However, this does not limit mitotic progression
because the CPC translocates to the spindle midzone in anaphase
and the dephosphorylation of RepoMan-S893 is taken over by
PP1. Thus, S893 is a common substrate of RepoMan-associated
PP2A-B56 and PP1, but at distinct phases of mitosis.
The consecutive dephosphorylation of a protein by distinct
phosphatases may be a more common feature of mitosis.
Possibly, it also accounts for discrepant findings on the relative
contribution of PP1 and PP2A-B56 to the dephosphorylation of
the kinetochore protein KNL1 (refs 32,33).
The PP1-mediated dephosphorylation of RepoMan at S893 in
anaphase is not restrained by Cdk1, which is no longer active and
is less efficiently counteracted by Aurora B after its translocation
to the spindle midzone (Fig. 8). Hence, the phosphatase switch in
anaphase makes the chromosome targeting of RepoMan largely
kinase-independent and irreversible, culminating in its bulk
recruitment to the chromosomes in anaphase. However, it should
be noted that even after its translocation to the spindle midzone
Aurora B still affects chromosome-associated processes through a
midzone gradient that is opposed by RepoMan, probably through
associated PP1 (refs 21,34). PP1-RepoMan also becomes
sufficiently active in anaphase to cause a net dephosphorylation
of the Importin-b-binding sites of RepoMan and Aurora B at
the chromosomes. It is possible that PP1-RepoMan also
dephosphorylates chromosome-associated substrates of Aurora
B, as suggested previously8,21, but our data do not allow us to
differentiate between effects on Aurora B and/or its substrates.
Recently, PP1-PP2A activation relay systems have been
described for the mitotic exit in fission yeast35 and spindle-
assembly checkpoint silencing in human cells33. The PP2A-PP1
switch on RepoMan in our study presents a new type of
phosphatase relay. However, at present it is not clear which
phosphatase dephosphorylates the Cdk1 sites in the PP1 and
PP2A-binding domains of RepoMan and induces the anaphase
switch in phosphatase binding. Our preliminary data suggest that
the activation of this ‘priming’ phosphatase not only requires the
inactivation of Cdk1 but also depends on a proteolytic event
(unpublished data), consistent with the existence of a hitherto
unidentified proteasome-activated mitotic-exit phosphatase36.
In conclusion, we have found that the activities of RepoMan-
associated PP2A-B56 and PP1 are coordinated by Cdk1 and that
this is essential for the ordered dephosphorylation of their
substrates in mitosis.
Methods
Materials. Antibodies against EGFP (SC-8334, Santa Cruz, 1:1,000), GAPDH
(2118, Cell Signaling, 1:5,000), H3S10ph (9706, Cell Signaling, 1:1,000), ACA
(HCT-0100, ImmunoVision, 1:4,000), Aurora B (611082, BD Transduction
Laboratories, 1:250), H3T3ph (07–424, Millipore, 1:10,000), RepoMan
(HPA030049, Sigma, 1:300 for IF, 1:1,000 for WB; Ab45129, Abcam, 1:1,000 for
WB), PP2A-Ca (610556, BD Transduction Laboratories, 1:2,000), PP2A-B56g
(sc-67038, Santa Cruz, 1:1,000), Lamin B1 (sc-6216, Santa Cruz, 1:500),
phospho-PP1 (2581S, Cell Signaling, 1:1,000), Importin b (ab2811, Abcam,
1:10,000 for IF, 1:2,000 for WB) and Nup153 (ab84872, abcam, 1:5,00) and
phospho-Ser/Thr-Pro, also known as mpm2 (Merckmillipore, 05–368, 1:1,000)
were purchased. MCAK antibodies were a gift from Dr Linda Wordeman
(University of Washington School of Medicine). Swine anti-rabbit IgG-HRP
(P0217, Dako,1:5,000), rabbit anti-mouse IgG-HRP (P0260, Dako,1:5,000), rabbit
anti-goat IgG-HRP (P0160, Dako,1:5,000), donkey anti-mouse, goat anti-rabbit
IgG-Alexa Fluor 488 (A11008, ab150109 from Invitrogen,1:1,000), goat anti-
mouse, goat anti-rabbit IgG-Alexa Fluor 546 (A11030, A11010 from Invitrogen,
1:1,000) and goat anti-mouse, goat anti-rabbit, goat anti-human IgG-Alexa Fluor
633 (A21052, A21070 and A21091 from Invitrogen,1:1,000) were also from com-
mercial sources. A non-isoform-specific PP1 antibody and a RepoMan phospho-
S893 antibody were made in house13,37 For the RepoMan S593nph antibody,
a synthetic peptide comprising residues 581–599 of RepoMan was coupled to
keyhole limpet haemocyanin or bovine serum albumin (BSA) (Imject Maleimide-
activated keyhole limpet hemocyanin/BSA kit, Pierce) and used to generate
antibody in rabbits. Similarly, the synthetic peptide LPANT(ph)PLRKGGC was
used to generate a RepoMan T412ph antibody in rabbits. Calyculin A (EI-192,
Biomol), Roscovitine (R-1234, LC Laboratories), Hesperadin (S1529, Selleckchem),
Monastrol (orb146117, Biorbyt) and Microcystin-LR (10007188, Cayman) were
purchased. Duplexes of siRNA against RepoMan (TGACAGACTTGACCAGAAA)
and control siRNA (TAAGGCTATGAAGAGATAC) were obtained from
Dharmacon. An siRNA-resistant EGFP-RepoMan construct was generated with
primers 50-GAG TCC GAG ATG ACG GAC TTA ACT AGG AAG GAA GGT
CTC AGC-30 and 50-GCT GAG ACC TTC CTT CCT AGT TAA GTC CGT CAT
CTC GGA CTC-30 . The indicated mutants were generated according to the
QuickChange Mutagenesis Kit (Agilent Technologies) and verified by sequencing.
Importin b1-EGFP and EGFP-CENPB-INCENP constructs were kind gifts from
Dr Patrizia Lavia (Institute of Molecular Biology and Pathology, Italy) and
Dr Susanne Lens (University Medical Center Utrecht, Netherland), respectively.
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Figure 8 | Model of the Cdk1-mediated coordination of RepoMan-associated phosphatases. During (pro)metaphase, Cdk1 promotes Aurora-B activation
and prevents nuclear-envelope reassembly through phosphorylation of RepoMan at multiple sites, which reduces the binding of PP1 and Importin b.
In contrast, the Cdk1-mediated phosphorylation of RepoMan at S591 enhances the recruitment of PP2A, which contributes to the dynamic chromosome
targeting of RepoMan in (pro)metaphase and the centromeric localization of Aurora B. After anaphase onset, Cdk1 inactivation leads to the
dephosphorylation of RepoMan, associated with the loss of PP2A and the bulk recruitment of PP1-RepoMan to the chromosomes. PP1-RepoMan then
inactivates Aurora B and promotes nuclear-envelope reassembly through dephosphorylation of Histone H3 at T3, Aurora B at T232 and RepoMan at S893
and the Importin-b-binding domain.
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Cell culture and transfections. HEK293T cells were cultured in high-glucose
DMEM, supplemented with 10% fetal calf serum (FCS). U2OS human
osteosarcoma cells were cultured in McCoy’s 5A medium with 10% FCS. HeLa cells
were cultured in low-glucose DMEM, supplemented with 10% FCS. All media
contained penicillin and streptomycin. Transfection with plasmid DNA was carried
out with X-tremeGENE 9 (Roche Applied Science) or jetPRIME (Polyplus
Transfection) transfection Reagent. The siRNA transfections or co-transfection of
plasmid DNA and siRNA were performed using jetPRIME transfection reagent for
48–60 h. Flp-In T-REx HeLa cells used for generating stable doxycycline-inducible
cell lines were a gift from Dr Jonathon Pines (University of Cambridge, England,
UK). Flp-In T-REx HeLa host cell lines were maintained in DMEM with 10%
tetracycline-free fetal bovine serum supplemented with 50 mgml 1 Zeocin.
siRNA-resistant constructs encoding EGFP-RepoMan variants were cloned into
pCDNA5/FRT/TO vectors (Invitrogen). All HeLa Flp-in cells stably expressing a
doxycycline-inducible construct of EGFP-RepoMan were derived from the HeLa
Flp-in host cell line by transfection with the pCDNA5/FRT/TO vector and pOG44
(Invitrogen), and cultured in the same medium but containing 200 mgml 1
hygromycin and 4 mgml 1 blasticidin. Gene expression was induced with
10 ngml 1 doxycycline (Sigma-Aldrich) for 24 h or as indicated. Unless indicated
otherwise, a prometaphase arrest was induced by culturing U2OS, HeLa, Hela
Flp-in TRex or HEK293T cells consecutively for 24 h with 2mM thymidine, 2 h
without thymidine and 16 h with 100 ngml 1 nocodazole or 100 mM Monastrol.
The arrested U2OS and HeLa cells were harvested by shake-off.
Biochemical procedures. For EGFP traps the soluble fraction (S1) after cell lysis
and the chromatin-enriched fraction (S2) after micrococcal nuclease (300Uml 1)
treatment were collected37. The rest pellet after the micrococcal nuclease treatment
was sonicated on ice water for 10min, and the supernatant (S3) was combined with
S1 and S2 for EGFP trapping of RepoMan fusions37. Similar cell lysates was
prepared for immunoprecipitations of endogenous RepoMan (HPA030049,1:100).
Of note, to preserve the phosphatase activity, the micrococcal nuclease treatment
step was omitted in the EGFP-RepoMan trap when the S893D mutation
was introduced (Figs 6k and 7l), and the sonication was shortened to 5min.
SDS–polyacrylamide gel electrophoresis was performed with 4–12%, 10% Bis-Tris
or 3–8% Tris-acetate gels (NuPAGE, Invitrogen) for Coomassie brilliant blue
staining or immunoblotting. For peptide pulldown, synthetic RepoMan-(581–599),
either unmodified or phosphorylated at S591, was coupled to Maleimide-activated
BSA (Pierce) via an additional C-terminal Cys residue. BSA or the BSA-linked
peptide was coupled to CNBr-activated Sepharose-4B (GE Healthcare). The matrix
was incubated with U2OS cell lysates. After washing with Tris-buffered solution
supplemented with 0.2M LiCl, the retained proteins were analysed for the presence
of PP2A by immunoblotting. Recombinant GST-tagged Aurora-B-(1–344) fused to
INCENP-(835–903) was expressed in bacteria and affinity purified13. Poly-His
tagged fragments were expressed in bacteria and purified on Ni2þ -Sepharose. For
in vitro phosphorylation, purified RepoMan-(865–925) was incubated for 60min at
30 C with recombinant GST-AuroraB-INCENP in a buffer containing 20mM
Tris/HCl at pH 7.5, 2mM dithiothreitol (DTT), 0.1mgml 1 BSA, 2mM MgAc
and 1mM ATP. For in vitro phosphorylation with Cdks, samples were incubated
for different time points at 30 C with recombinant Cdk1/Cyclin B1 (0134–0135–1,
Proqinase) or Cdk2/Cyclin A (homemade) in a buffer containing 20mM Tris/HCl
at pH 7.5, 2mM DTT, 0.1mgml 1 BSA, 2mM MgAc and 1mM ATP or
100mM g32P-labelled ATP. Microcystin (0.5 mM) was added if no further
dephosphorylation assay was followed. For in vitro dephosphorylation, 1 mg of
Aurora-B-phosphorylated His-RepoMan-(865–925) or Cdk-phosphorylated
His-RepoMan-(1–135) was incubated for indicated time points at 30 C in a shaker
with PP1 purified from rabbit skeletal muscle or an EGFP trap of the indicated
fusions in a buffer containing 20mM Tris/HCl at pH 7.5, 0.1mgml 1 BSA
and 1mM DTT in a total volume of 40 ml. Immunoblots were visualized using
ECL reagent (Perkin Elmer) in an ImageQuant LAS4000 imaging system
(GE Healthcare). Uncropped versions of blots appear in Supplementary Fig. 7.
Coomassie brilliant blue stained radioactive gels were visualized with the Typhoon
FLA 9500 system (GE Healthcare).
Immunofluorescence staining and microscopy. For immunofluorescence
studies, cells were consecutively grown on polylysine-coated coverslips in a 24-well
chamber, fixed with 4% paraformaldehyde, permeabilized with 0.5% Triton X-100,
blocked in 3% BSA/PBS and incubated in 1.5% BSA/PBS with the primary
antibodies overnight at 4 C, and with secondary antibodies for 1 h at room
temperature. The DNA was stained with DAPI (fixed) or Hoechst 33342 (live
imaging). Confocal images were acquired with a Leica TCS SPE laser-scanning
confocal system mounted on a Leica DMI 4000B microscope and equipped with a
Leica ACS APO 63X 1.30NA oil DIC objective. For live cell imaging, the Leica TCS
SPE laser-scanning confocal microscope was further equipped with a live-imaging
chamber ensuring 37 C and 5% CO2, and a monochrome digital camera DFC365
FX from Leica. For time-lapse imaging, cells were grown in a four-well chambered
coverglass (LabTek, Thermo Fisher Scientific). All immunofluorescence images of
similarly stained experiments were acquired with identical illumination settings.
The brightness and contrast were adjusted using only linear operations applied to
the entire image. Final images were processed and assembled using Photoshop
CS3 (Adobe). For quantification, Z-stack scans were performed through each cell
(8–10 sections with 1 mm intervals for H3T3ph, H3S10ph and Aurora B T232ph;
five sections with 0.5 mm intervals for MCAK and Mad2 ), and analysed using
ImageJ software with the ‘sum slices’ feature of Z project. MCAK and Mad2
fluorescence intensity was quantified for individual kinetochores selected manually
by ACA staining after subtraction of the background signal (estimated from
regions of the cell without kinetochores). The normalized ratio against ACA was
plotted with Origin 8.5 software (OriginLab software).
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